Canadians being treated for cancer deserve equitable access to the most effective, proven cancer treatments available at costs that they and the healthcare system can afford. However, achieving and then sustaining equitable access across Canada while the cancer burden continues to grow will require a thoughtful, deliberate, and balanced approach. Funding cancer treatment today must preserve the healthcare system’s ability to fund care and treatment tomorrow.
Innovative ways of funding the growing demand for cancer care and treatment, including access to cancer drugs, must be explored if Canada is going to ensure sustainability of Canada’s cancer system and healthcare system. One of the most promising approaches includes the implementation of the pan-Canadian Oncology Drug Review (pCODR).